[儿童和成人多动症的药理治疗]
Per Hove Thomsen1, Tine Houmann2, Pelle Lau Ishøy3
1Børne- og Ungdomspsykiatrisk Afdeling, Aarhus Universitetshospital Psykiatrien.
Ugeskrift for laeger
|May 14, 2025
概括
药物治疗,包括兴奋剂和非兴奋剂药物,有效地管理所有年龄段的注意力缺陷多动症 (ADHD) 核心症状. 综合性ADHD治疗需要将药物与心理社会干预和定期医生监测相结合.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 注意缺陷多动症 (ADHD) 是一种影响全球数百万人的神经发育障碍.
- 药物治疗是有效的ADHD管理策略的基石.
- 基于证据的治疗指南强调多式联络方法.
研究的目的:
- 对ADHD的兴奋剂和非兴奋剂药物的疗效进行审查.
- 概述启动和监测药物治疗ADHD的最佳实践.
- 强调将药物治疗与心理社会干预相结合的重要性.
主要方法:
- 对有关ADHD药物治疗的现有文献进行系统审查.
- 分析支持兴奋剂和非兴奋剂药物类别的证据.
- 检查ADHD治疗启动和随访的临床指南.
主要成果:
- 兴奋剂和非兴奋剂药物都在缓解ADHD核心症状方面表现出显著的有效性.
- 建议医生或专家启动药物治疗.
- 卫生当局建议每两年进行一次后续检查.
结论:
- 药理干预对于儿童和成人综合性多动症治疗至关重要.
- 最佳的ADHD管理需要将药物与心理社会支持相结合.
- 坚持推的治疗方案可确保改善患者的治疗结果.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.6K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.1K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
27
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
27
Alzheimer's Disease: Treatment
132
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
132
Adrenergic Agonists: Therapeutic Uses
689
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
689
Drug Therapy
30
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
30
Parkinson's Disease: Treatment
158
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
158
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
141
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
141
